NASDAQ Gainers: JetBlue Airways Corporation (NASDAQ:JBLU), Sodastream International (NASDAQ:SODA), Celldex Therapeutics (NASDAQ:CLDX), Cerner Corporation (NASDAQ:CERN)

JetBlue Airways Corporation (NASDAQ:JBLU), was upgraded by analysts at Argus from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday,TheFlyOnTheWall.com reports. JetBlue Airways Corporation (NASDAQ:JBLU), shares after opening at $8.50 moved to $8.84 on last trade day and at the end of the day closed at $8.80. Company price to sales ratio in past twelve months was calculated as 0.48 and price to cash ratio as 4.17. JetBlue Airways Corporation (NASDAQ:JBLU), showed a negative weekly performance of 2.11%.

It is being reported that Sodastream International Ltd (NASDAQ:SODA) is in negotiations to offload between 10 to 16% of its holding at a share price of $52. This essentially values the company at $1.1 billion. Sodastream International Ltd (NASDAQ:SODA) shares advanced 8.12% in last trading session and ended the day on $40.75. Sodastream International Ltd (NASDAQ:SODA),return on equity ratio is recorded as 13.50% and its return on assets is 9.30%. Sodastream International Ltd (NASDAQ:SODA),yearly performance is -21.72%.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) on Apr. 7 reported results of preclinical studies evaluating the anti-tumor activity of CDX-014 against a variety of cell lines. Based on the results, CDX-014 will enter clinical development. CDX-014 is an antibody drug conjugate (ADC) that targets the protein TIM-1 (T cell immunoglobulin and mucin domain). TIM-1 expression is upregulated in several cancers, including renal cell and ovarian carcinomas. It is associated with kidney injury and the shedding of its ectodomain is a predictive biomarker for tumor progression. TIM-1 has very restricted expression in healthy tissues, making it a promising target for antibody mediated therapy. Celldex Therapeutics, Inc. (NASDAQ:CLDX), shares moved up 6.99% in last trading session and was closed at $14.69, while trading in range of $ 13.66 – 14.82. Celldex Therapeutics, Inc. (NASDAQ:CLDX), year to date (YTD) performance is -39.32%.

On April 7, 2014 Cerner Corporation (NASDAQ:CERN) announced it will release its first quarter 2014 earnings results after the market closes on April 24. There will be a conference call at 3:30 p.m. CDT that can be accessed via dial-in or webcast. Cerner Corporation (NASDAQ:CERN), weekly performance is -2.30%. On last trading day company shares ended up $53.98. Cerner Corporation (NASDAQ:CERN), distance from 50-day simple moving average (SMA50) is -6.95%. Analysts mean target Price for the company is $62.33.